Overconsumption of information stands in the way of creativity.
During an interview on Andy Cohen’s satellite radio show Radio Andy, actress Melissa Gilbert claimed that director Oliver Stone sexually harassed her during an audition for his 1991 film The Doors. At first, Gilbert told her story without naming any names. She kept the accusations very anonymous saying that she was humiliated during an audition because she had “embarrassed him in a social situation.” Gilbert ended up running out of the room crying.
A new technique has yielded clues to the role of centromeres in Down syndrome, which arises when a child inherits an extra copy of chromosome 21.A new technique could give scientists access to the “final frontier” of our DNA—the centromere. It’s in nearly every one of our cells, at the center of every X-shaped chromosome, and it plays a crucial role in the everyday cell division that keeps us healthy. Which also makes it a key suspect in birth defects, cancers, and other diseases that arise from cell division problems.
I confess to being troubled rather than elated by the daily rumble of idols falling to accusations of “sexual misconduct,” the morbid masscult fixation that conceals private titillation, knowing smirks, and sadistic lip-smacking behind a public mask of solemn reproof… By William Kaufman.
Nanomachines which can drill into cancer cells, killing them in just 60 seconds, have been developed by scientists. The tiny spinning molecules are driven by light, and spin so quickly that they can burrow their way through cell linings when activated. In one test conducted at Durham University the nanomachines took between one and three minutes to break through the outer membrane of prostate cancer cell, killing it instantly.
Time and again, healthcare experts have doubted the ability of Watson to help fight cancer. But the findings of a new study pose an argument in favor of IBM’s flagship artificial intelligence (AI) technology. Led by the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, researchers employed Watson for Genomics to dig into “large volumes of data” from studies and databases, along with genetic information, to target treatment options and clinical trials for 1018 patients with “tumors with specific genetic abnormalities.”